IGC Acquires Exclusive Rights for a Potential Alzheimer’s Drug Development Candidate
BETHESDA, Md.–(BUSINESS WIRE)–#IGC–India Globalization Capital, Inc. (NYSE: IGC) is excited to announce that one of its subsidiaries reached an Intellectual Property (IP) license agreement for a potential Alzheimer’s drug development candidate. Researchers at the Jawaharlal Nehru Centre for Advanced Scientific Research (“JNCASR”), in India, conducted about 10 years of research and discovery work on NMI … [Read more…]
